在他汀类药物不耐受的患有或有心血管疾病风险的成年人中，贝匹地酸在中位数为 41 个月时降低了 MACE。
In statin-intolerant adults with, or at risk for, CV disease, bempedoic acid reduced MACE at a median 41 mo.
机构信息
Division of Cardiology and Duke Clinical Research Institute, Duke University, Durham, North Carolina, USA (M.D.K., L.K.N.).
出版信息
Ann Intern Med. 2023 Jul;176(7):JC75. doi: 10.7326/J23-0044. Epub 2023 Jul 4.
DOI:10.7326/J23-0044
PMID:37399554
Abstract
Nissen SE, Lincoff MA, Brennan D, et al; CLEAR Outcomes Investigators. N Engl J Med. 2023;388:1353-1364. 36876740.
摘要
Nissen SE, Lincoff MA, Brennan D, et al; CLEAR Outcomes Investigators. N Engl J Med. 2023;388:1353-1364. 36876740.
Zotero 插件